Resources

Positive news ahead of Spending Review (join our webinar this Friday), latest on getting pensions investment into UK life sciences and more!

Pension capital is unlocked in time for BIA's Parliament Day this Wednesday.

The Mansion House Accord signed on 13 May and the publication of the Government’s Pensions Investment Review mark the latest developments in the BIA’s campaign to unlock pension funds for life sciences. Here, our Director of Policy and External Affairs, Dr Martin Turner, reflects on how we got to this point and what must happen next.

The proposals outlined in the report are a major step towards realising BIA’s long-held goal of increasing investment from UK pension funds into UK life sciences.

We are heading to Boston this June for the BIO International Convention 2025 – one of the world’s largest and most influential gatherings in the life sciences calendar. 

Cellestial Health, a pioneering pharmaceutical development spin-out from the University of Cambridge, has closed a £515,000 pre-seed equity funding round to accelerate the development of novel therapeutics targeting astrocytes, an often-overlooked cell type in the brain, with the first indication of Parkinson’s disease.

BIA publishes its 10-year Vision for the UK life science sector, the culmination of 18 months of research and engagement with members and the broader life science ecosystem.

We are calling on the UK government to mandate pension funds to invest in high-growth UK sectors, as new data from its latest report shows British pension schemes are still missing from the biggest biotech deals. 

This week I highlight innovation across the sector and call on pension funds to be mandated to support our industry.

NCIMB Limited ("NCIMB") has secured a £1.7m investment from the Investment Fund for Scotland, managed by Maven Capital Partners (“Maven”) and the Scottish National Investment Bank.

Washington’s shifting policy landscape continues to cause uncertainty, while the UK is staying calm. Join our webinar this Thursday to hear how we’re engaging with international partners and government to ensure the UK voice is heard and our sector remains robust.